OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
Kathleen M. McAndrews, Sara P.Y., Valerie S. LeBleu, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100523-100523
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

The roles of extracellular vesicles in the immune system
Edit I. Buzás
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 236-250
Open Access | Times Cited: 622

The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 234

Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 186

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 184

Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
Lamiaa El-Shennawy, Andrew D. Hoffmann, Nurmaa K. Dashzeveg, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 134

New advances in exosome-based targeted drug delivery systems
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 84

Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy
Anubhab Mukherjee, Bharti Bisht, Suman Dutta, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 11, pp. 2759-2776
Open Access | Times Cited: 71

Selective STING stimulation in dendritic cells primes antitumor T cell responses
Bakhos Jneid, Aurore Bochnakian, Caroline Hoffmann, et al.
Science Immunology (2023) Vol. 8, Iss. 79
Open Access | Times Cited: 67

Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 36

Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Wu Manling, Min Wang, Haoyuan Jia, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2513-2538
Open Access | Times Cited: 45

Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 30

Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 28

Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 26

Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review
Nicola Salvatore Orefice, Rossella Di Raimo, Davide Mizzoni, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 2, pp. 89-100
Open Access | Times Cited: 26

Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles
Xiao Cheng, Brian S. Henick, Ke Cheng
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6748-6765
Closed Access | Times Cited: 11

Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities
Jilong Cao, Gang Lv, Wei Fang
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 11

The biology and function of extracellular vesicles in immune response and immunity
Raghu Kalluri
Immunity (2024) Vol. 57, Iss. 8, pp. 1752-1768
Closed Access | Times Cited: 10

Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 9

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 6

Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

A Review on Relevance of Nanosomes in Contemporary Therapeutics: Innovative Approach to Drug Delivery
Kumar Janakiraman, Vaidevi Sethuraman, Gracesuganthi Jayaraj
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access

Application of nanoparticles with activating STING pathway function in tumor synergistic therapy
Yi Yang, Yaning Fang, Xin‐Yu Du, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114013-114013
Closed Access

Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics
Hojun Choi, Hwayoung Yim, Cheolhyoung Park, et al.
Membranes (2022) Vol. 12, Iss. 1, pp. 85-85
Open Access | Times Cited: 27

cGAMP the travelling messenger
Henry T.W. Blest, Lise Chauveau
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19

Page 1 - Next Page

Scroll to top